U.S. Hematology Analyzers Market Size & Outlook, 2019-2027

The hematology analyzers market in the United States is expected to reach a projected revenue of US$ 416.4 million by 2027. A compound annual growth rate of 4.8% is expected of the United States hematology analyzers market from 2020 to 2027.
Revenue, 2019 (US$M)
$286.2
Forecast, 2027 (US$M)
$416.4
CAGR, 2020 - 2027
4.8%
Report Coverage
U.S.

U.S. hematology analyzers market highlights

  • The U.S. hematology analyzers market generated a revenue of USD 286.2 million in 2019 and is expected to reach USD 416.4 million by 2027.
  • The U.S. market is expected to grow at a CAGR of 4.8% from 2020 to 2027.
  • In terms of segment, 3-part fully automated hematology analyzers was the largest revenue generating product in 2019.
  • 5-Part Fully Automated Hematology Analyzers is the most lucrative product segment registering the fastest growth during the forecast period.


Hematology analyzers market data book summary

Market revenue in 2019USD 286.2 million
Market revenue in 2027USD 416.4 million
Growth rate4.8% (CAGR from 2019 to 2027)
Largest segment3-part fully automated hematology analyzers
Fastest growing segment5-Part Fully Automated Hematology Analyzers
Historical data2016 - 2018
Base year2019
Forecast period2020 - 2027
Quantitative unitsRevenue in USD million
Market segmentation3-Part Fully Automated Hematology Analyzers, 5-Part Fully Automated Hematology Analyzers, 6-Part Fully Automated Hematology Analyzers, Semi-Automated Hematology Analyzers, Controls and Calibrators
Key market players worldwideAbbott Laboratories, Beckman Coulter, Horiba Ltd, Siemens AG, Sysmex Corp, Nihon Kohden Corp, Bio-Rad Laboratories Inc, Mindray Medical International, Roche Holding AG ADR, Boule Diagnostics AB


Other key industry trends

  • In terms of revenue, U.S. accounted for 32.0% of the global hematology analyzers market in 2019.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In North America, U.S. hematology analyzers market is projected to lead the regional market in terms of revenue in 2027.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 63.3 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hematology Analyzers Market Companies

Name Profile # Employees HQ Website

U.S. hematology analyzers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hematology analyzers market will help companies and investors design strategic landscapes.


3-part fully automated hematology analyzers was the largest segment with a revenue share of 35.78% in 2019. Horizon Databook has segmented the U.S. hematology analyzers market based on 3-part fully automated hematology analyzers, 5-part fully automated hematology analyzers, 6-part fully automated hematology analyzers, semi-automated hematology analyzers, controls and calibrators covering the revenue growth of each sub-segment from 2016 to 2027.


Reasons to subscribe to U.S. hematology analyzers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. hematology analyzers market databook

  • Our clientele includes a mix of hematology analyzers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. hematology analyzers market, including forecasts for subscribers. This country databook contains high-level insights into U.S. hematology analyzers market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. hematology analyzers market size, by product, 2016-2027 (US$M)

U.S. Hematology Analyzers Market Share, 2019 & 2027 (US$M)

U.S. hematology analyzers market size, by product, 2016-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more